{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:52:24Z","timestamp":1791978744437,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-026-10224-1","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:14:14Z","timestamp":1784394854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Densitometric gains do not uniformly translate into clinical and psychosocial recovery: a 12-month multidimensional analysis of romosozumab therapy in postmenopausal osteoporosis"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-8120","authenticated-orcid":false,"given":"\u00d6mer Faruk","family":"Bucak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-6345","authenticated-orcid":false,"given":"Cigdem","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8959-6522","authenticated-orcid":false,"given":"Eser","family":"Kalaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-2759","authenticated-orcid":false,"given":"Umit","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-3672","authenticated-orcid":false,"given":"\u0130brahim Halil","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3738-7627","authenticated-orcid":false,"given":"Evrim","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8051-9245","authenticated-orcid":false,"given":"Yusuf","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"3","key":"10224_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd. Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467\u201375.","journal-title":"Bone"},{"issue":"10","key":"10224_CR2","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA. 2022;33(10):2049\u2013102.","journal-title":"Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA"},{"issue":"1","key":"10224_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11657-025-01533-4","volume":"20","author":"\u00d6F Bucak","year":"2025","unstructured":"Bucak \u00d6F, Cinar C. The Role of ChatGPT in osteoporosis management: a comparative analysis with clinical expertise. Arch Osteoporos. 2025;20(1):51.","journal-title":"Arch Osteoporos"},{"issue":"16","key":"10224_CR4","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, et al. Romosozumab Treatment in Postmenopausal Women with Osteoporosis. N Engl J Med. 2016;375(16):1532\u201343.","journal-title":"N Engl J Med"},{"issue":"15","key":"10224_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, et al. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. N Engl J Med. 2017;377(15):1417\u201327.","journal-title":"N Engl J Med"},{"issue":"10102","key":"10224_CR6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","volume":"390","author":"BL Langdahl","year":"2017","unstructured":"Langdahl BL, Libanati C, Crittenden DB, et al. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet (London England). 2017;390(10102):1585\u201394.","journal-title":"Lancet (London England)"},{"issue":"1","key":"10224_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/acr2.11619","volume":"6","author":"NE Lane","year":"2024","unstructured":"Lane NE, Betah D, Deignan C, Oates M, Wang Z, Timoshanko J, et al. Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial. ACR Open Rheumatol. 2024;6(1):43\u201351.","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10224_CR8","doi-asserted-by":"publisher","first-page":"22441","DOI":"10.1038\/s41598-025-05187-7","volume":"15","author":"Y Sobue","year":"2025","unstructured":"Sobue Y, Kosugiyama H, Asai S, Ogawa Y, Yoneda M, Maruyama K, et al. A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis. Sci Rep. 2025;15(1):22441.","journal-title":"Sci Rep"},{"key":"10224_CR9","doi-asserted-by":"crossref","unstructured":"Naegeli AN, Nixon A, Burge R, Gold DT, Silverman S. Development of the Osteoporosis Assessment Questionnaire\u2013physical Function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(2):579\u201388.","DOI":"10.1007\/s00198-013-2448-9"},{"issue":"10","key":"10224_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40266-017-0492-4","volume":"34","author":"A Catalano","year":"2017","unstructured":"Catalano A, Martino G, Morabito N, et al. Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach. Drugs Aging. 2017;34(10):755\u201365.","journal-title":"Drugs Aging"},{"issue":"3","key":"10224_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0304-3959(99)00242-0","volume":"85","author":"JWS Vlaeyen","year":"2000","unstructured":"Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85(3):317\u201332.","journal-title":"Pain"},{"issue":"6","key":"10224_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/AJP.0b013e3182385392","volume":"28","author":"G Crombez","year":"2012","unstructured":"Crombez G, Eccleston C, Van Damme S, Vlaeyen JW, Karoly P. Fear-avoidance model of chronic pain: the next generation. Clin J Pain. 2012;28(6):475\u201383.","journal-title":"Clin J Pain"},{"issue":"1","key":"10224_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10865-006-9085-0","volume":"30","author":"M Leeuw","year":"2007","unstructured":"Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007;30(1):77\u201394.","journal-title":"J Behav Med"},{"key":"10224_CR14","doi-asserted-by":"crossref","unstructured":"Giangregorio LM, Papaioannou A, Macintyre NJ, et al. Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(3):821\u201335.","DOI":"10.1007\/s00198-013-2523-2"},{"key":"10224_CR15","doi-asserted-by":"crossref","unstructured":"Hallberg I, Rosenqvist AM, Kartous L, L\u00f6fman O, Wahlstr\u00f6m O, Toss G. Health-related quality of life after osteoporotic fractures. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2004;15(10):834\u201341.","DOI":"10.1007\/s00198-004-1622-5"},{"key":"10224_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40842-018-0062-7","volume":"4","author":"P Choksi","year":"2018","unstructured":"Choksi P, Jepsen KJ, Clines GA. The challenges of diagnosing osteoporosis and the limitations of currently available tools. Clin diabetes Endocrinol. 2018;4:12.","journal-title":"Clin diabetes Endocrinol"},{"issue":"Suppl 11","key":"10224_CR17","first-page":"S240","volume":"63","author":"GA Hawker","year":"2011","unstructured":"Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res. 2011;63(Suppl 11):S240\u201352.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10224_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00002508-199103000-00053","volume":"7","author":"RP Miller","year":"1991","unstructured":"Miller RP, Kori S, Todd D. The Tampa Scale: a measure of kinesiophobia. Clin J Pain. 1991;7(1):51\u20132.","journal-title":"Clin J Pain"},{"key":"10224_CR19","doi-asserted-by":"crossref","unstructured":"Zigmond AS, Snaith RP. (1983). The hospital anxiety and depression scale. Acta psychiatrica Scandinavica. 1983;67(6), 361\u2013370.","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"10224_CR20","doi-asserted-by":"crossref","unstructured":"Lips P, Cooper C, Agnusdei D et al. (1997). Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 1997;7(1), 36\u201338.","DOI":"10.1007\/BF01623457"},{"issue":"1","key":"10224_CR21","first-page":"44","volume":"22","author":"\u00d6T Yilmaz","year":"2011","unstructured":"Yilmaz \u00d6T, Yakut Y, Uygur F, Ulu\u011f N. Tampa Kinezyofobi \u00d6l\u00e7e\u011fi\u2019nin T\u00fcrk\u00e7e versiyonu ve test-tekrar test g\u00fcvenirli\u011fi. Fizyoterapi Rehabilitasyon. 2011;22(1):44\u20139.","journal-title":"Fizyoterapi Rehabilitasyon"},{"issue":"4","key":"10224_CR22","first-page":"280","volume":"8","author":"\u00d6 Aydemir","year":"1997","unstructured":"Aydemir \u00d6. Hastane Anksiyete ve Depresyon \u00d6l\u00e7e\u011fi T\u00fcrk\u00e7e formunun ge\u00e7erlilik ve g\u00fcvenilirli\u011fi. T\u00fcrk Psikiyatri Dergisi. 1997;8(4):280\u20137.","journal-title":"T\u00fcrk Psikiyatri Dergisi"},{"issue":"1","key":"10224_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10067-002-0653-6","volume":"22","author":"H Ko\u00e7yigit","year":"2003","unstructured":"Ko\u00e7yigit H, G\u00fclseren S, Erol A, Hizli N, Memis A. The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Clin Rheumatol. 2003;22(1):18\u201323.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10224_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","volume":"22","author":"CR Shuhart","year":"2019","unstructured":"Shuhart CR, Yeap SS, Anderson PA, et al. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin densitometry: official J Int Soc Clin Densitometry. 2019;22(4):453\u201371.","journal-title":"J Clin densitometry: official J Int Soc Clin Densitometry"},{"issue":"301","key":"10224_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","volume":"58","author":"JH Ward Jr","year":"1963","unstructured":"Ward JH Jr. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963;58(301):236\u201344.","journal-title":"J Am Stat Assoc"},{"issue":"9","key":"10224_CR26","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00198-024-07155-9","volume":"35","author":"J Everts-Graber","year":"2024","unstructured":"Everts-Graber J, Wenger M, Oser S, et al. The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland. Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA. 2024;35(9):1605\u201313.","journal-title":"Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA"},{"issue":"5","key":"10224_CR27","doi-asserted-by":"publisher","first-page":"105219","DOI":"10.1016\/j.jbspin.2021.105219","volume":"88","author":"K Ebina","year":"2021","unstructured":"Ebina K, Tsuboi H, Nagayama Y, et al. Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis. Joint bone spine. 2021;88(5):105219.","journal-title":"Joint bone spine"},{"key":"10224_CR28","doi-asserted-by":"crossref","unstructured":"Cosman F, Kendler DL, Langdahl BL, et al. Romosozumab and antiresorptive treatment: the importance of treatment sequence. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2022;33(6):1243\u201356.","DOI":"10.1007\/s00198-021-06174-0"},{"issue":"9","key":"10224_CR29","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.3735","volume":"34","author":"P Chavassieux","year":"2019","unstructured":"Chavassieux P, Chapurlat R, Portero-Muzy N, et al. Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment. J bone mineral research: official J Am Soc Bone Mineral Res. 2019;34(9):1597\u2013608.","journal-title":"J bone mineral research: official J Am Soc Bone Mineral Res"},{"key":"10224_CR30","doi-asserted-by":"crossref","unstructured":"Adami G, Montanari F, Fassio A, et al. Increase in serum DKK1 levels attenuates the anabolic response to romosozumab in postmenopausal osteoporosis. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2026;41(2):143\u20139.","DOI":"10.1093\/jbmr\/zjaf110"},{"issue":"5","key":"10224_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00198-004-1762-7","volume":"16","author":"P Lips","year":"2005","unstructured":"Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA. 2005;16(5):447\u201355.","journal-title":"Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA"},{"key":"10224_CR32","doi-asserted-by":"crossref","unstructured":"Oleksik AM, Ewing S, Shen W, van Schoor NM, Lips P. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2005;16(8):861\u201370.","DOI":"10.1007\/s00198-004-1774-3"},{"key":"10224_CR33","first-page":"58","volume-title":"Prevalence and influencing factors of kinesiophobia in older patients with primary osteoporosis: A cross-sectional survey","author":"FF Lyu","year":"2024","unstructured":"Lyu FF, Ying H, Zhang M, Xia LR, Liu Q, Cai L. Prevalence and influencing factors of kinesiophobia in older patients with primary osteoporosis: A cross-sectional survey. Volume 57. New York, N.Y.: Geriatric nursing; 2024. p. 58\u201365."},{"issue":"5","key":"10224_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.23736\/S1973-9087.18.04931-6","volume":"54","author":"Z Gunendi","year":"2018","unstructured":"Gunendi Z, Eker D, Tecer D, Karaoglan B. Is the word osteoporosis a reason for kinesiophobia? Eur J Phys Rehabil Med. 2018;54(5):671\u20135.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"5","key":"10224_CR35","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/jbmr.292","volume":"26","author":"JA Cauley","year":"2011","unstructured":"Cauley JA, Black D, Boonen S, Cummings SR, Mesenbrink P, Palermo L, et al. Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial. J Bone Min Res. 2011;26(5):984\u201392.","journal-title":"J Bone Min Res"},{"issue":"7","key":"10224_CR36","doi-asserted-by":"publisher","first-page":"e10191","DOI":"10.1002\/jbm4.10191","volume":"3","author":"S Hayashi","year":"2019","unstructured":"Hayashi S, Fukuda K, Maeda T, Chinzei N, Kihara S, Miura Y, et al. Denosumab Treatment Improved Health-Related Quality of Life in Osteoporosis: A Prospective Cohort Study. JBMR Plus. 2019;3(7):e10191.","journal-title":"JBMR Plus"},{"issue":"8","key":"10224_CR37","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s00198-011-1856-y","volume":"23","author":"P Hadji","year":"2012","unstructured":"Hadji P, Zanchetta JR, Russo L, Recknor CP, Saag KG, McKiernan FE, et al. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporos Int. 2012;23(8):2141\u201350.","journal-title":"Osteoporos Int"},{"issue":"15","key":"10224_CR38","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.3390\/ijerph18158144","volume":"18","author":"G Martino","year":"2021","unstructured":"Martino G, Bellone F, Vicario CM, et al. Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up. Int J Environ Res Public Health. 2021;18(15):8144.","journal-title":"Int J Environ Res Public Health"},{"issue":"13","key":"10224_CR39","first-page":"2902","volume":"15","author":"D Agostini","year":"2023","unstructured":"Agostini D, Donati Zeppa S, Vitamin D. Diet Musculoskelet Health Nutrients. 2023;15(13):2902.","journal-title":"Diet Musculoskelet Health Nutrients"},{"key":"10224_CR40","doi-asserted-by":"crossref","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2019;30(1):3\u201344.","DOI":"10.1007\/s00198-018-4704-5"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-026-10224-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:37:04Z","timestamp":1791977824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-026-10224-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10224"],"URL":"https:\/\/doi.org\/10.1186\/s12891-026-10224-1","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the study was obtained from the Ethics Committee of Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital (Approval No. 2025-272, dated August 27, 2025). All procedures involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants prior to inclusion.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"866"}}